Literature DB >> 9892568

Primarily infected cephalhematoma and osteomyelitis in a newborn.

C J Miedema1, M Ruige, J L Kimpen.   

Abstract

Cephalhematomas are subperiosteal blood collections occurring in newborns secondary to trauma at birth. They develop within a few days and are subsequently resorbed. Infection of a cephalhematoma is unusual and caused most often by colonization of the hematoma during bacteremia or by direct inoculation secondary to trauma. Less than 10 patients with primary infection of the hematoma, in the absence of a positive blood culture, complicated by osteomyelitis have been described. We report a newborn with a primarily infected cephalhematoma complicated by parietal bone osteomyelitis.

Entities:  

Mesh:

Year:  1999        PMID: 9892568

Source DB:  PubMed          Journal:  Eur J Med Res        ISSN: 0949-2321            Impact factor:   2.175


  5 in total

1.  Escherichia coli septicaemia arising as a result of an infected caput succedaneum.

Authors:  Sanjay Rawal; Neha Modi; Sandra Lacey; Morgan Keane
Journal:  Eur J Pediatr       Date:  2005-09-03       Impact factor: 3.183

2.  Osteomyelitis of skull with underlying brain abscess.

Authors:  Rajniti Prasad; Nishant Verma; O P Mishra; A Srivastava
Journal:  Indian J Pediatr       Date:  2011-02-23       Impact factor: 1.967

3.  Infected cephalhaematoma causing osteomyelitis: case report and literature review.

Authors:  Asfand Baig Mirza; Timothy Boardman; Samantha Ashworth; Wisam Al-Faiadh; Razna Ahmed; José Pedro Lavrador; Eleni Maratos; Chris Chandler; Cristina Bleil; Bassel Zebian
Journal:  J Surg Case Rep       Date:  2022-05-27

Review 4.  Infected cephalohematomas and underlying osteomyelitis: a case-based review.

Authors:  Michael D Staudt; Daniel Etarsky; Adrianna Ranger
Journal:  Childs Nerv Syst       Date:  2016-04-11       Impact factor: 1.475

Review 5.  Infected cephalhaematoma in a five-week-old infant - case report and review of the literature.

Authors:  Petra Zimmermann; Andrea Duppenthaler
Journal:  BMC Infect Dis       Date:  2016-11-04       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.